CVE-2023-0967
CVE-2023-0967 is a medium-severity vulnerability in Imaworldhealth Bhima with a CVSS 3.x base score of 6.5. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-639.
Key facts
- Severity: Medium (CVSS 3.x base score 6.5)
- EPSS exploit prediction: 1% (48th percentile)
- Actively exploited: Not listed in CISA KEV
- Weakness: CWE-639
- Affected product: Imaworldhealth Bhima
- Published:
- Last modified:
Description
Bhima version 1.27.0 allows an attacker authenticated with normal user permissions to view sensitive data of other application users and data that should only be viewed by the administrator. This is possible because the application is vulnerable to IDOR, it does not properly validate user permissions with respect to certain actions the user can perform.
Frequently asked questions
- What is CVE-2023-0967?
- Bhima version 1.27.0 allows an attacker authenticated with normal user permissions to view sensitive data of other application users and data that should only be viewed by the administrator. This is possible because the application is vulnerable to IDOR, it does not properly validate user permissions with respect to certain actions the user can perform.
- How severe is CVE-2023-0967?
- CVE-2023-0967 has a CVSS 3.x base score of 6.5, rated medium severity. It is exploitable over network with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity none, and availability none.
- Is CVE-2023-0967 being actively exploited?
- It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (48th percentile), an estimate of the probability of exploitation in the next 30 days.
- What products are affected by CVE-2023-0967?
- CVE-2023-0967 affects Imaworldhealth Bhima. See the affected-products list for the exact vulnerable versions.
- How do I fix CVE-2023-0967?
- Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
- When was CVE-2023-0967 published?
- CVE-2023-0967 was published on 2023-04-05 and last updated on 2026-06-17.
References
Affected products (1)
- cpe:2.3:a:imaworldhealth:bhima:1.27.0:*:*:*:*:*:*:*
More vulnerabilities in Imaworldhealth Bhima
- CVE-2023-0959 — Medium (CVSS 6.5): Bhima version 1.27.0 allows a remote attacker to update the privileges of any account registered in the application via…
- CVE-2023-0944 — Medium (CVSS 4.3): Bhima version 1.27.0 allows an authenticated attacker with regular user permissions to update arbitrary user session…
All CVEs affecting Imaworldhealth Bhima →
Other CWE-639 (Authorization Bypass Through User-Controlled Key (IDOR)) vulnerabilities
- CVE-2025-40805 — Critical (CVSS 10.0): Affected devices do not properly enforce user authentication on specific API endpoints. This could facilitate an…
- CVE-2024-45032 — Critical (CVSS 10.0): A vulnerability has been identified in Industrial Edge Management Pro (All versions < V1.9.5), Industrial Edge…
- CVE-2026-34037 — Critical (CVSS 9.9): Coolify is an open-source and self-hostable tool for managing servers, applications, and databases. Prior to…
- CVE-2026-52782 — Critical (CVSS 9.9): OpenProject is open-source, web-based project management software. Prior to 17.3.3 and 17.4.1, there is an IDOR through…
- CVE-2026-45552 — Critical (CVSS 9.9): Roxy-WI is a web interface for managing Haproxy, Nginx, Apache and Keepalived servers. In versions 8.2.6.4 and prior,…
- CVE-2026-29200 — Critical (CVSS 9.9): A critical IDOR vulnerability has been discovered in Comet Backup affecting all versions from 20.11.0 to 26.1.1 and…
Browse all CWE-639 (Authorization Bypass Through User-Controlled Key (IDOR)) vulnerabilities →